Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-α immunotherapy

Cancer

Volumn 92, Issue 2, 2001, Pages 369-376

  Ugurel, Selma ^a   Rebmann, Vera ^b   Ferrone, Soldano ^c   Tilgen, Wolfgang ^a   Grosse Wilde, Hans ^b   Reinhold, Uwe ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Enzyme linked immunoadsorbent assay (ELISA); Interferon (IFN ) therapy; Medical oncology; Melanoma; Prognosis; Soluble human leukocyte antigen G

Indexed keywords

ALPHA INTERFERON; CISPLATIN; CYTOSTATIC AGENT; DACARBAZINE; HLA G ANTIGEN; TEMOZOLOMIDE; VINCRISTINE;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL PROTECTION; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MELANOMA; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL; TUMOR VOLUME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON-ALPHA; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0035878632     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U     Document Type: Article

References (25)

1. The functionality of HLA-G is emerging
2. HLA-G: A tolerance molecule from the major histocompatibility complex
3. Immunotolerant functions of HLA-G
4. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
5. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
6. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells
7. Expression of HLA-G in human tumors is not a frequent event
8. Looking for HLA-G expression in human tumours
9. HLA-G class I gene expression in normal and malignant hematopoietic cells
10. HLA-G protein expression is not induced during malignant transformation
11. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation
12. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain
13. Detection of soluble HLA-G molecules in plasma and amniotic fluid
14. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens
15. Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies
16. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma
17. Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
18. Interferons in melanoma
19. Interferons: Laboratory to clinic investigations
20. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment
21. Cytokine regulation of HLA-G expression in human trophoblast cell lines
22. Expression of HLA-G in human mononuclear phagocytes and selective induction by 1FN-gamma
23. Soluble HLA-G in human placentas: Synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts
24. Interferons enhance HLA-G mRNA and protein in transfected mouse fibroblasts